Shares in Natco Rally On Hepatitis Approval

Posted By:
Subscribe to GoodReturns

Shares in Natco rallied after the company received an approval for generic Hepatitis C medicine. The stock was up over 5 per cent at Rs 1,963 on the National Stock Exchange.

Shares in Natco Rally On Hepatitis Approval
Natco Pharma: Quotes, News
BSE 588.05BSE Quote12.7 (2.16%)
NSE 588.25NSE Quote13.05 (2.22%)
It also hit a new 52-week high of Rs 1984 in intra day trading.

"Natco Pharma is pleased to announce that it is the 1st company in India to get approval for generic sofosbuvir tablets, 400mg, from Drugs Controller General (India)," the company said in a press release.

GoodReturns.in

Read more about: natco
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?